drugset / Trial / NCT01011777
Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to study safety, tolerability and efficacy of muscle derived cell (MDC) therapy in children with bladder exstrophy epispadias induced urinary incontinence.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2020-01-23
- Completion
- 2020-01-23
Outcome
Outcome not reported
Stopped: “Due to participants withdrawal prior to anticipated end of study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MDC | Cell therapy | 2e+07 cells | Other |